Kangmei Pharma reported CNY2.38B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Akebia Therapeutics USD 13.02M 22K Jun/2026
Avita Medical AUD 6.93M 614K Dec/2025
Cspc Pharmaceutical CNY 3.09B 219.95M Dec/2025
Genomma Lab Internacional MXN 1.95B 14.37M Jun/2026
Hypermarcas BRL 2.07B 13.22M Mar/2026
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Jiangsu Hengrui CNY 2.88B 137.72M Dec/2025
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Moderna USD 280M 134M Jun/2026
Organon & Co USD 1.37B 33M Mar/2026
Revvity USD 378.5M 9M Jun/2026
Sh Fosun Pharma CNY 6.25B 582.75M Dec/2025
Viatris USD 3.93B 6.2M Jun/2026
Wuxi Apptec CNY 9.97B 972.64M Mar/2026
Xeris Pharmaceuticals USD 80.93M 6.7M Jun/2026
Zz Pientze Pharmaceu CNY 6.28B 553.86M Mar/2026